Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Bacillus subtilis (strain 168) | ATP-dependent Clp protease proteolytic subunit | Starlite/ChEMBL | No references |
Homo sapiens | glucosidase, beta, acid | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | electron transfer protein FdxB | 0.0145 | 0.1315 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0312 | 0.3957 | 1 |
Treponema pallidum | ATP-dependent Clp protease proteolytic subunit | 0.0094 | 0.0515 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0145 | 0.1315 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0312 | 0.3957 | 1 |
Wolbachia endosymbiont of Brugia malayi | ATP-dependent Clp protease proteolytic subunit | 0.0094 | 0.0515 | 0.5 |
Plasmodium vivax | stearoyl-CoA desaturase (acyl-CoA desaturase, faty acid desaturase), putative | 0.0549 | 0.7705 | 1 |
Mycobacterium ulcerans | transmembrane alkane 1-monooxygenase AlkB | 0.0145 | 0.1315 | 1 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0094 | 0.0515 | 0.5 |
Mycobacterium tuberculosis | Probable conserved membrane protein | 0.0145 | 0.1315 | 0.5161 |
Echinococcus multilocularis | ATP dependent Clp protease proteolytic subunit | 0.0094 | 0.0515 | 0.3918 |
Mycobacterium tuberculosis | Possible electron transfer protein FdxB | 0.0145 | 0.1315 | 0.5161 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0312 | 0.3957 | 1 |
Echinococcus multilocularis | Peptidase M, neutral zinc metallopeptidases, zinc binding site | 0.0145 | 0.1315 | 1 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0094 | 0.0515 | 0.5 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0223 | 0.2547 | 1 |
Echinococcus granulosus | Fatty acid desaturase type 1 | 0.0145 | 0.1315 | 1 |
Loa Loa (eye worm) | O-glycosyl hydrolase family 30 protein | 0.0312 | 0.3957 | 0.4787 |
Brugia malayi | Delta5 fatty acid desaturase | 0.0145 | 0.1315 | 0.1112 |
Mycobacterium ulcerans | linoleoyl-CoA desaturase, DesA3 | 0.0145 | 0.1315 | 1 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.0549 | 0.7705 | 0.7358 |
Onchocerca volvulus | Glucosylceramidase homolog | 0.0205 | 0.226 | 0.1088 |
Loa Loa (eye worm) | hypothetical protein | 0.0145 | 0.1315 | 0.1112 |
Brugia malayi | acyl-CoA desaturase | 0.0549 | 0.7705 | 1 |
Echinococcus granulosus | Sphingolipid delta4 desaturase DES1 | 0.0145 | 0.1315 | 1 |
Brugia malayi | O-Glycosyl hydrolase family 30 protein | 0.0312 | 0.3957 | 0.4787 |
Loa Loa (eye worm) | fatty acid desaturase | 0.0145 | 0.1315 | 0.1112 |
Brugia malayi | Fatty acid desaturase family protein | 0.0145 | 0.1315 | 0.1112 |
Onchocerca volvulus | 0.0694 | 1 | 1 | |
Loa Loa (eye worm) | FAT-3 protein | 0.0145 | 0.1315 | 0.1112 |
Mycobacterium tuberculosis | Probable transmembrane alkane 1-monooxygenase AlkB (alkane 1-hydroxylase) (lauric acid omega-hydroxylase) (omega-hydroxylase) (f | 0.0145 | 0.1315 | 0.5161 |
Echinococcus granulosus | ATP dependent Clp protease proteolytic subunit | 0.0094 | 0.0515 | 0.3918 |
Mycobacterium ulcerans | linoleoyl-CoA desaturase, DesA3 | 0.0145 | 0.1315 | 1 |
Echinococcus multilocularis | Fatty acid desaturase, type 1 | 0.0145 | 0.1315 | 1 |
Leishmania major | fatty-acid desaturase, putative | 0.0694 | 1 | 1 |
Brugia malayi | Fatty acid desaturase family protein | 0.0145 | 0.1315 | 0.1112 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0216 | 0.2434 | 0.1027 |
Toxoplasma gondii | sphingolipid delta 4 desaturase/c-4 hydroxylase protein des2 family protein | 0.0145 | 0.1315 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0216 | 0.2434 | 0.1027 |
Mycobacterium ulcerans | hypothetical protein | 0.0145 | 0.1315 | 1 |
Onchocerca volvulus | 0.0694 | 1 | 1 | |
Loa Loa (eye worm) | fatty acid desaturase | 0.0145 | 0.1315 | 0.1112 |
Echinococcus multilocularis | Peptidase M, neutral zinc metallopeptidases, zinc binding site | 0.0145 | 0.1315 | 1 |
Trypanosoma brucei | fatty acid desaturase, putative | 0.0694 | 1 | 1 |
Loa Loa (eye worm) | acyl-CoA desaturase | 0.0549 | 0.7705 | 1 |
Plasmodium falciparum | stearoyl-CoA desaturase | 0.0549 | 0.7705 | 1 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.0694 | 1 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0312 | 0.3957 | 1 |
Schistosoma mansoni | fatty acid desaturase | 0.0145 | 0.1315 | 1 |
Mycobacterium ulcerans | linoleoyl-CoA desaturase, DesA3_2 | 0.0145 | 0.1315 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0312 | 0.3957 | 1 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.0549 | 0.7705 | 0.7358 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 CLPP2 (ENDOPEPTIDASE CLP 2) | 0.0094 | 0.0515 | 1 |
Trichomonas vaginalis | glucosylceramidase, putative | 0.0312 | 0.3957 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 10 uM | PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 25.1189 uM | PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Potency (binding) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.